HUMAN EPITHELIAL OVARIAN-CANCER CELL STEROID-SECRETION AND ITS CONTROL BY GONADOTROPINS

被引:51
作者
WIMALASENA, J
MEEHAN, D
CAVALLO, C
机构
[1] University of Nebraska Medical Center, Department of Physiology, Omaha, NE 68198-4575
关键词
D O I
10.1016/0090-8258(91)90255-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To elucidate the role of gonadotropins in regulating steroid metabolism in human epithelial ovarian carcinoma (OV Ca), cells were cultured from a number of OV Ca localized to the ovary. These cells uniformly secreted 17-β-estradiol (E2), and cells from some OV Ca also secreted progesterone (P), as well as CA 125. Secretion rates decreased with time in culture and number of subcultures. In the original and first few subcultures, 1-10 pg/ml/μg DNA/24 hr of E2 was secreted and P secretion varied from 1 to 8 ng/ml/μg DNA/24 hr under basal conditions. Secretion rates for CA 125 were between 5 and 300 U/ml/day. Approximately 30% of the primary cultures from cystadenocarcinomas responded to hCG and hFSH and 70% of cultures responded to 8-Br-cAMP with 2- to 10-fold increases in secretion of E2. In one primary culture, hCG produced a dose-related increase in E2 production between 1 and 5 ng/ml, but the response declined to zero at 25 ng/ml. In the same cells, exposure to hCG and cAMP for 72 hr produced cell death, whereas hFSH had no such effect. Subculturing reduced steroidogenic responses to the hormones but the response to cAMP was maintained to a greater degree. These results suggest that some OV Ca-derived cells are steroidogenic in vitro and that some of these cells respond with increased E2 secretion to agents which are well-known stimulators of steroidogenesis in normal ovarian cells. © 1991.
引用
收藏
页码:56 / 63
页数:8
相关论文
共 42 条
[1]  
AIMAN J, 1986, OBSTET GYNECOL, V68, P1
[2]   AN IMMUNOHISTOCHEMICAL STUDY OF THE INCIDENCE AND SIGNIFICANCE OF HUMAN GONADOTROPIN AND PROLACTIN BINDING-SITES IN NORMAL AND NEOPLASTIC HUMAN OVARIAN TISSUE [J].
ALTIMIMI, A ;
BUCKLEY, CH ;
FOX, H .
BRITISH JOURNAL OF CANCER, 1986, 53 (03) :321-329
[3]   PROGESTERONE AS A POSSIBLE TUMOR-MARKER FOR NON-ENDOCRINE OVARIAN MALIGNANT-TUMORS [J].
BACKSTROM, T ;
MAHLCK, CG ;
KJELLGREN, O .
GYNECOLOGIC ONCOLOGY, 1983, 16 (01) :129-138
[4]   A RADIOIMMUNOASSAY USING A MONOCLONAL-ANTIBODY TO MONITOR THE COURSE OF EPITHELIAL OVARIAN-CANCER [J].
BAST, RC ;
KLUG, TL ;
STJOHN, E ;
JENISON, E ;
NILOFF, JM ;
LAZARUS, H ;
BERKOWITZ, RS ;
LEAVITT, T ;
GRIFFITHS, CT ;
PARKER, L ;
ZURAWSKI, VR ;
KNAPP, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (15) :883-887
[5]  
BLEEHEN NM, 1985, OVARIAN CANCER, P1
[7]  
CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P717
[8]  
DONALDSON ES, 1980, CANCER-AM CANCER SOC, V45, P948, DOI 10.1002/1097-0142(19800301)45:5<948::AID-CNCR2820450519>3.0.CO
[9]  
2-Q
[10]   STEROID-RECEPTORS AND RESPONSE OF OVARIAN-CANCER TO HORMONES INVITRO [J].
GRONROOS, M ;
KANGAS, L ;
MAENPAA, J ;
VANHARANTA, R ;
NIEMINEN, AL ;
JOHANSSON, R .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1984, 91 (05) :472-478